Infectious Disease Point of Care Diagnostics market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Infectious Disease Point of Care Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Infectious Disease Point of Care Diagnostics market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Over-the-counter (OTC) Testing Kits
Prescription-based Testing Kits
Segment by Application
Bacterial Infections
Fungal Infection
Virus Infection
Cardiovascular Infection
Gastrointestinal Infection
Sexually Transmitted Disease (STD) Infection
Central Nervous System Infection
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Abbott
Siemens
GE Healthcare
Accriva
Terumo
BioMerieux
Diasorin
Roche
Danaher Corporation
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
Euroimmun
Gold Standard Diagnostics
Hologic
Immunetics
InBios International